Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring
- 1 March 1999
- journal article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 4 (1), 3-8
- https://doi.org/10.1177/107424849900400102
Abstract
Background: The VA Stroke Prevention in Nonrheumatic Atrial Fibrillation study was a prospective, randomized, double-blind study comparing low-dose warfarin with placebo in patients with nonrheumatic atrial fibrillation. The trial showed a 79% reduction in stroke rate in warfarin randomized patients without an increase in bleeding complications. We examined the need for frequent prothrombin time monitoring (international normalized ratios [INR] were not measured directly) in patients receiving warfarin. Methods and Results: Patients were initiated on 4.0 mg/d warfarin with a goal of main taining the prothrombin time ratio (PTR) within the range of 1.2-1.5 (estimated INR: 1.4-2.8). PTR monitoring was performed weekly during a 12-week induction period and monthly thereafter for a total follow-up of 3 years. Two hundred sixty patients were ran domized to receive warfarin. During the induction period, the proportion of patients whose PTRs were in the desired range increased from 28% at 1 week postrandomization to 65% at 12 weeks postrandomization; the proportion of patients requiring a dose adjustment decreased from 52% to 16% during the same period. During the maintenance period, the mean proportion of patients whose PTRs were within 1.2-1.5 was 60.5% ± 6.2%. Conclusions: Low-dose anticoagulation with warfarin in outpatients should be initiated at the anticipated maintenance dose. This approach reduces the chance of being out of range on the high side. Weekly INR estimation during this phase seems optimal. Considerable dose adjusting was required during the maintenance phase to keep patients within range; monthly INRs are required. Because of the need for dose adjustments, fixed-dose warfarin regimens are unlikely to keep patients in the desired narrow therapeutic range.Keywords
This publication has 10 references indexed in Scilit:
- Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarctionThe Lancet, 1997
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial FibrillationThe New England Journal of Medicine, 1996
- Anticoagulation in Atrial FibrillationArchives of Internal Medicine, 1994
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of Internal Medicine, 1994
- A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve ReplacementThe New England Journal of Medicine, 1993
- Risk Factors for Complications of Chronic Anticoagulation: A Multicenter StudyAnnals of Internal Medicine, 1993
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationThe New England Journal of Medicine, 1992
- Home Prothrombin Time Monitoring after the Initiation of Warfarin TherapyAnnals of Internal Medicine, 1989
- Cost Effectiveness of Monitoring Warfarin Therapy Using Standard Versus Capillary Prothrombin TimesAmerican Journal of Clinical Pathology, 1989